{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:44:27Z","timestamp":1790315067931,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In-stent restenosis (ISR) represents a major complication after stenting of intracranial artery stenosis (ICAS). Biomarkers derived from routine blood sampling including C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and mean platelet volume (MPV) have been associated with progressive atherosclerosis. We investigated the role of CRP, NLR, PLR and MPV on the development of intracranial ISR and recurrent stroke risk. We retrospectively included all patients who had undergone stenting of symptomatic ICAS at our university hospital between 2005 and 2016. ISR (\u2265\u200950% stenosis) was diagnosed by regular Duplex sonography follow-up studies and confirmed by digital subtraction angiography or computed tomography angiography (mean follow-up duration: 5\u00a0years). Laboratory parameters were documented before stenting, at the time of restenosis and at last clinical follow-up. Of 115 patients (mean age: 73\u2009\u00b1\u200913\u00a0years; female: 34%), 38 (33%) developed ISR. The assessed laboratory parameters did not differ between patients with ISR and those without (p\u2009&gt;\u20090.1). While ISR was associated with the occurrence of recurrent ischemic stroke (p\u2009=\u20090.003), CRP, NLR, PLR and MPV were not predictive of such events (p\u2009&gt;\u20090.1). Investigated blood biomarkers of progressive atherosclerosis were not predictive for the occurrence of ISR or recurrent ischemic stroke after ICAS stenting during a 5-year follow-up.<\/jats:p>","DOI":"10.1038\/s41598-021-95135-y","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T10:03:01Z","timestamp":1627898581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Melanie","family":"Haidegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kneihsl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Niederkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Deutschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mangge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerit","family":"W\u00fcnsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fandler-H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Enzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gattringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"95135_CR1","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(13)70195-9","volume":"12","author":"CA Holmstedt","year":"2013","unstructured":"Holmstedt, C. A., Turan, T. N. & Chimowitz, M. I. Atherosclerotic intracranial arterial stenosis: Risk factors, diagnosis, and treatment. Lancet Neurol. 12, 1106\u20131114 (2013).","journal-title":"Lancet Neurol."},{"key":"95135_CR2","volume":"2013","author":"D Ding","year":"2013","unstructured":"Ding, D., Starke, R. M., Crowley, R. W. & Liu, K. C. Role of stenting for intracranial atherosclerosis in the post-SAMMPRIS era. BioMed Res. Int. 2013, 304320 (2013).","journal-title":"BioMed Res. Int."},{"key":"95135_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jvs.2010.08.057","volume":"52","author":"SG Zhu","year":"2010","unstructured":"Zhu, S. G. et al. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. J. Vasc. Surg. 52, 1114 (2010).","journal-title":"J. Vasc. Surg."},{"key":"95135_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","volume":"352","author":"MI Chimowitz","year":"2005","unstructured":"Chimowitz, M. I. et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 352, 1305\u20131316 (2005).","journal-title":"N. Engl. J. Med."},{"key":"95135_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1161\/STROKEAHA.108.532713","volume":"40","author":"K Gr\u00f6schel","year":"2009","unstructured":"Gr\u00f6schel, K., Schnaudigel, S., Pilgram, S. M., Wasser, K. & Kastrup, A. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 40, 340\u2013347 (2009).","journal-title":"Stroke"},{"key":"95135_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1105335","volume":"365","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz, M. I. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 365, 993\u20131003 (2011).","journal-title":"N. Engl. J. Med."},{"key":"95135_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.2015.1693","volume":"313","author":"BF Zaidat","year":"2015","unstructured":"Zaidat, B. F. et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: The VISSIT randomized clinical trial. JAMA 313, 1240\u20131248 (2015).","journal-title":"JAMA"},{"key":"95135_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/svn-2017-000137","volume":"3","author":"N Ma","year":"2018","unstructured":"Ma, N. et al. Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study. Stroke Vasc. Neurol. 3, 176\u2013184 (2018).","journal-title":"Stroke Vasc. Neurol."},{"key":"95135_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","volume":"383","author":"CP Derdeyn","year":"2014","unstructured":"Derdeyn, C. P. et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): The final results of a randomised trial. Lancet 383, 333\u2013341 (2014).","journal-title":"Lancet"},{"key":"95135_CR10","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1161\/STROKEAHA.110.594739","volume":"41","author":"S Amin-Hanjani","year":"2010","unstructured":"Amin-Hanjani, S. et al. Detection of intracranial in-stent restenosis using quantitative magnetic resonance angiography. Stroke 41, 2534\u20132538 (2010).","journal-title":"Stroke"},{"key":"95135_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/jcm8101593","volume":"8","author":"K Guetl","year":"2019","unstructured":"Guetl, K. et al. The white blood cell count to mean platelet volume ratio for the prediction of chronic limb-threatening ischemia in lower extremity artery disease. J. Clin. Med. 8, 1593 (2019).","journal-title":"J. Clin. Med."},{"key":"95135_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12872-018-0812-6","volume":"18","author":"S Zhang","year":"2018","unstructured":"Zhang, S. et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A meta-analysis. BMC Cardiovasc. Disord. 18, 75 (2018).","journal-title":"BMC Cardiovasc. Disord."},{"key":"95135_CR13","doi-asserted-by":"publisher","first-page":"6513847","DOI":"10.1155\/2019\/6513847","volume":"2019","author":"CVJ Serrano","year":"2019","unstructured":"Serrano, C. V. J. et al. Association between neutrophil-lymphocyte and platelet-lymphocyte ratios and coronary artery calcification score among asymptomatic patients: Data from a cross-sectional study. Mediat. Inflamm. 2019, 6513847 (2019).","journal-title":"Mediat. Inflamm."},{"key":"95135_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1538-7836.2009.03584.x","volume":"8","author":"SG Chu","year":"2010","unstructured":"Chu, S. G. et al. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J. Thromb. Haemost. 8, 148\u2013156 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"95135_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/STROKEAHA.117.019748","volume":"49","author":"Z Dai","year":"2018","unstructured":"Dai, Z. et al. Mean platelet volume as a predictor for restenosis after carotid angioplasty and stenting. Stroke 49, 872\u2013876 (2018).","journal-title":"Stroke"},{"key":"95135_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0003319715583186","volume":"67","author":"MK Akboga","year":"2016","unstructured":"Akboga, M. K. et al. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology 67, 89\u201395 (2016).","journal-title":"Angiology"},{"key":"95135_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/STROKEAHA.119.028180","volume":"51","author":"M Haidegger","year":"2020","unstructured":"Haidegger, M. et al. Mean platelet volume does not predict restenosis after carotid artery stenting in Whites. Stroke 51, 986\u2013989 (2020).","journal-title":"Stroke"},{"key":"95135_CR18","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 39, 3021\u20133104 (2018).","journal-title":"Eur. Heart J."},{"key":"95135_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.7326\/M15-3016","volume":"164","author":"JJ Chamberlain","year":"2016","unstructured":"Chamberlain, J. J. et al. Diagnosis and management of diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann. Intern. Med. 164, 542\u2013552 (2016).","journal-title":"Ann. Intern. Med."},{"key":"95135_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","volume":"24","author":"G De Backer","year":"2003","unstructured":"De Backer, G. et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur. Heart J. 24, 1601\u20131610 (2003).","journal-title":"Eur. Heart J."},{"key":"95135_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner, Z. et al. 2011 ESC\/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 32, 1769\u20131818 (2011).","journal-title":"Eur. Heart J."},{"key":"95135_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HJH.0b013e3283220fd1","volume":"27","author":"G Manciaa","year":"2009","unstructured":"Manciaa, G. et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J. Hypertens. 27, 1\u201338 (2009).","journal-title":"J. Hypertens."},{"key":"95135_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","volume":"7","author":"PM Bath","year":"1996","unstructured":"Bath, P. M. & Butterworth, R. J. Platelet size: Measurement, physiology and vascular disease. Blood Coagul. Fibrinolysis 7, 157\u2013161 (1996).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"95135_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3904\/kjim.2016.078","volume":"31","author":"DH Choi","year":"2016","unstructured":"Choi, D. H., Kang, S. H. & Song, H. Mean platelet volume: A potential biomarker of the risk and prognosis of heart disease. Korean J. Intern. Med. 31, 1009\u20131017 (2016).","journal-title":"Korean J. Intern. Med."},{"key":"95135_CR25","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1038\/s41598-018-25058-8","volume":"8","author":"P Rief","year":"2018","unstructured":"Rief, P. et al. Low mean platelet volume is associated with critical limb ischemia in peripheral arterial occlusive disease. Sci. Rep. 8, 6718 (2018).","journal-title":"Sci. Rep."},{"key":"95135_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0003319718784805","volume":"70","author":"Z Dai","year":"2018","unstructured":"Dai, Z. et al. Neutrophil to lymphocyte ratio as a predictor of restenosis after angioplasty and stenting for asymptomatic carotid stenosis. Angiology 70, 160\u2013165 (2018).","journal-title":"Angiology"},{"key":"95135_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/2394-8108.162531","volume":"1","author":"J Arenillas","year":"2015","unstructured":"Arenillas, J. Intracranial atherosclerosis and inflammation: Lessons from the East and the West. Brain Circ. 1, 47\u201352 (2015).","journal-title":"Brain Circ."},{"key":"95135_CR28","first-page":"77","volume":"20","author":"R Gupta","year":"2008","unstructured":"Gupta, R., Bhatt, A., Kassab, M. & Majid, A. Elevated levels of pre-procedural high-sensitivity C-reactive protein is associated with midterm restenosis after extra- and intracranial stenting. J. Neuroimaging 20, 77 (2008).","journal-title":"J. Neuroimaging"},{"key":"95135_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/STROKEAHA.107.498600","volume":"39","author":"JF Arenillas","year":"2008","unstructured":"Arenillas, J. F. et al. Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 39, 1456\u20131463 (2008).","journal-title":"Stroke"},{"key":"95135_CR30","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1161\/01.STR.0000089920.93927.A7","volume":"34","author":"JF Arenillas","year":"2003","unstructured":"Arenillas, J. F. et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34, 2463\u20132470 (2003).","journal-title":"Stroke"},{"key":"95135_CR31","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/0898264315569453","volume":"27","author":"EM Friedman","year":"2015","unstructured":"Friedman, E. M., Christ, S. L. & Mroczek, D. K. Inflammation partially mediates the association of multimorbidity and functional limitations in a national sample of middle-aged and older adults: The MIDUS study. J. Aging Health 27, 843\u2013863 (2015).","journal-title":"J. Aging Health"},{"key":"95135_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/eci.12184","volume":"44","author":"FJ Mayer","year":"2014","unstructured":"Mayer, F. J. et al. Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease. Eur. J. Clin. Investig. 44, 22\u201328 (2014).","journal-title":"Eur. J. Clin. Investig."},{"key":"95135_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jocn.2012.01.051","volume":"20","author":"XB Lai","year":"2019","unstructured":"Lai, X. B. et al. Predictors of in-stent stenosis and occlusion after endovascular treatment of intracranial vascular disease with the Willis covered stent. J. Clin. Neurosci. 20, 122\u2013127 (2019).","journal-title":"J. Clin. Neurosci."},{"key":"95135_CR34","volume":"34","author":"L Tao","year":"2020","unstructured":"Tao, L., ShiChuan, W., DeTai, Z. & Lihua, H. Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction. J. Clin. Lab. Anal. 34, e23084 (2020).","journal-title":"J. Clin. Lab. Anal."},{"key":"95135_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2015.05.006","volume":"241","author":"PK Garg","year":"2015","unstructured":"Garg, P. K. et al. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis. Atherosclerosis 241, 176\u2013182 (2015).","journal-title":"Atherosclerosis"},{"key":"95135_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2017.05.014","volume":"262","author":"A Agarwala","year":"2017","unstructured":"Agarwala, A. et al. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis 262, 131\u2013137 (2017).","journal-title":"Atherosclerosis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95135-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95135-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:58:35Z","timestamp":1670068715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-95135-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["95135"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-95135-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]},"assertion":[{"value":"2 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15599"}}